{"id":27295,"date":"2026-01-16T14:52:31","date_gmt":"2026-01-16T17:52:31","guid":{"rendered":"https:\/\/sobelconsult.com\/the-new-fda-cosmetics-recalls-landscape\/"},"modified":"2026-10-26T22:02:11","modified_gmt":"2026-10-27T01:02:11","slug":"recall-cosmeticos-fda","status":"publish","type":"post","link":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","title":{"rendered":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">As atualiza\u00e7\u00f5es regulat\u00f3rias recentes mostram um movimento claro das autoridades globais: mais rigor t\u00e9cnico, mais transpar\u00eancia e maior expectativa de controle ao longo de todo o ciclo de vida dos produtos. <strong>Um exemplo est\u00e1 no recall de cosm\u00e9ticos<\/strong>, que passa a ganhar um novo <a href=\"https:\/\/sobelconsult.com\/pt-br\/registro-de-cosmeticos-estados-unidos\/\">peso regulat\u00f3rio nos Estados Unidos<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Neste artigo, reunimos os principais destaques regulat\u00f3rios recentes envolvendo FDA, Uni\u00e3o Europeia e China. Entenda <strong>como esse cen\u00e1rio pode impactar empresas que atuam em mercados altamente regulados!<\/strong> <\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-fda-issues-draft-guidance-on-mandatory-cosmetics-recalls\"><strong>FDA publica draft guidance sobre recalls obrigat\u00f3rios de cosm\u00e9ticos<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">O <a href=\"https:\/\/www.fda.gov\/cosmetics\/cosmetics-news-events\/fda-issues-draft-guidance-industry-questions-and-answers-regarding-mandatory-cosmetics-recalls\">Food and Drug Administration publicou um draft guidance<\/a> intitulado <em>\u201cQuestions and Answers Regarding Mandatory Cosmetics Recalls: Orienta\u00e7\u00e3o para o setor\u201d.<\/em> O objetivo \u00e9 de esclarecer <strong>como a ag\u00eancia pretende exercer sua autoridade legal para determinar recalls obrigat\u00f3rios,<\/strong> conforme previsto no MoCRA.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O documento detalha crit\u00e9rios, etapas do processo e expectativas regulat\u00f3rias aplic\u00e1veis quando um produto cosm\u00e9tico adulterado ou rotulado de forma inadequada representa risco s\u00e9rio \u00e0 sa\u00fade do consumidor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Na pr\u00e1tica, o material <strong>sinaliza uma mudan\u00e7a relevante na forma como o recall de cosm\u00e9ticos deve ser tratado pelas empresas.<\/strong> Tamb\u00e9m refor\u00e7a que a atua\u00e7\u00e3o do FDA n\u00e3o depende mais exclusivamente de a\u00e7\u00f5es volunt\u00e1rias do fabricante.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Embora o guidance ainda esteja em vers\u00e3o preliminar, ele reflete o entendimento atual do FDA sobre a aplica\u00e7\u00e3o de sua autoridade legal. Isso indica expectativas mais elevadas quanto \u00e0 maturidade dos sistemas de p\u00f3s-mercado, \u00e0 gest\u00e3o de reclama\u00e7\u00f5es, \u00e0 rastreabilidade de produtos e \u00e0 capacidade de resposta r\u00e1pida diante de eventos adversos. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Para empresas que fabricam, exportam ou comercializam cosm\u00e9ticos nos Estados Unidos, esse cen\u00e1rio refor\u00e7a a necessidade de revisar processos internos, planos de conting\u00eancia e documenta\u00e7\u00e3o t\u00e9cnica. O recall de cosm\u00e9ticos deixa de ser um evento excepcional e passa a integrar o planejamento regulat\u00f3rio cont\u00ednuo, com impacto direto na gest\u00e3o de riscos e na prote\u00e7\u00e3o da marca. <\/p>\n\n\n\n<div class=\"wp-block-group sb-cta sb-cta-svc is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"sb-cta-eye wp-block-paragraph\">Cosm\u00e9ticos \u00b7 EUA<\/p>\n\n\n\n<p class=\"sb-cta-title wp-block-paragraph\">Prepare-se para a fiscaliza\u00e7\u00e3o ampliada do FDA sobre cosm\u00e9ticos<\/p>\n\n\n\n<p class=\"sb-cta-out wp-block-paragraph\"><a href=\"https:\/\/sobelconsult.com\/pt-br\/home\/nossas-solucoes-2\/cosmetico\/?utm_source=blog&#038;utm_medium=cta&#038;utm_campaign=the-new-fda-cosmetics-recalls-landscape\">Conhe\u00e7a as solu\u00e7\u00f5es para cosm\u00e9ticos \u2192<\/a><\/p>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-european-union-considers-simplifying-mdr-requirements\"><strong>Uni\u00e3o Europeia avalia simplifica\u00e7\u00e3o do MDR<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Al\u00e9m dos recalls de cosm\u00e9ticos da FDA, o ambiente regulat\u00f3rio europeu tamb\u00e9m est\u00e1 evoluindo. A Comiss\u00e3o Europeia <a href=\"https:\/\/www.medtechdive.com\/news\/eu-proposal-simplify-mdr\/808398\/\">prop\u00f4s a simplifica\u00e7\u00e3o de determinados requisitos do Regulamento de Dispositivos M\u00e9dicos (MDR)<\/a>. O objetivo \u00e9 reduzir a carga regulat\u00f3ria sem comprometer a seguran\u00e7a dos produtos. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A iniciativa pode influenciar prazos de avalia\u00e7\u00e3o, obriga\u00e7\u00f5es de p\u00f3s-mercado e a atua\u00e7\u00e3o dos Notified Bodies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Embora <strong>o foco seja dispositivos m\u00e9dicos e IVDs<\/strong>, esse movimento refor\u00e7a uma tend\u00eancia comum tamb\u00e9m observada no setor de cosm\u00e9ticos: ajustes regulat\u00f3rios para equilibrar controle, previsibilidade e efici\u00eancia.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-mdcg-reinforces-post-market-surveillance-expectations\"><strong>MDCG refor\u00e7a expectativas de vigil\u00e2ncia p\u00f3s-mercado<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Complementando esse cen\u00e1rio, o Medical Device Coordination Group (MDCG) publicou <a href=\"https:\/\/www.raps.org\/news-and-articles\/news-articles\/2026\/1\/mdcg-outlines-postmarket-surveillance-expectations\">orienta\u00e7\u00f5es atualizadas sobre a vigil\u00e2ncia p\u00f3s-comercializa\u00e7\u00e3o na Europa<\/a>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O documento enfatiza a coleta sistem\u00e1tica de dados, a an\u00e1lise cont\u00ednua de riscos e a coer\u00eancia entre PMS, PMCF e gest\u00e3o de riscos.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>A mensagem \u00e9 clara: <\/strong>autoridades esperam abordagens estruturadas e proativas de p\u00f3s-mercado.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-china-reviews-requirements-for-new-cosmetic-ingredients\"><strong>China revisa requisitos para novos ingredientes cosm\u00e9ticos<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Enquanto temos recall de cosm\u00e9ticos em um mercado <strong>na \u00c1sia,  <\/strong>a National Medical Products Administration (NMPA) <a href=\"https:\/\/cosmetic.chemlinked.com\/news\/cosmetic-news\/chinas-nmpa-seeks-public-feedback-on-revised-nci-dossier\">abriu uma consulta p\u00fablica para revisar os requisitos do dossi\u00ea para Novos Ingredientes Cosm\u00e9ticos (NCI<\/a>).<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1000\" height=\"714\" src=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services.jpg\" alt=\"M&#xE3;os femininas escrevendo com uma caneta em um tubo contendo um l&#xED;quido amarelo. Abaixo, relat&#xF3;rios impressos. Na mesa ao lado, h&#xE1; um laptop e outros instrumentos de an&#xE1;lise.  \" class=\"wp-image-10787\" srcset=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services.jpg 1000w, https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services-300x214.jpg 300w, https:\/\/sobelconsult.com\/wp-content\/uploads\/2025\/07\/photo-cosmetics-services-768x548.jpg 768w\" sizes=\"(max-width: 1000px) 100vw, 1000px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">As mudan\u00e7as propostas podem afetar dados exigidos, prazos de avalia\u00e7\u00e3o e estrat\u00e9gias de entrada no mercado chin\u00eas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Para marcas que avaliam expans\u00e3o internacional, <strong>esse movimento indica um esfor\u00e7o das autoridades chinesas para ajustar processos regulat\u00f3rios, ampliar previsibilidade e, ao mesmo tempo, manter controle sobre seguran\u00e7a e inova\u00e7\u00e3o.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-a-global-shift-toward-greater-regulatory-accountability\"><strong>Um cen\u00e1rio global de maior responsabilidade regulat\u00f3ria<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Quando analisadas em conjunto, essas atualiza\u00e7\u00f5es revelam uma tend\u00eancia global: <strong>maior rigor t\u00e9cnico, expectativas claras sobre p\u00f3s-mercado e fortalecimento das ferramentas regulat\u00f3rias das autoridades<\/strong>. No caso dos Estados Unidos, isso se traduz diretamente em uma abordagem mais estruturada e menos reativa ao recall de cosm\u00e9ticos, exigindo preparo pr\u00e9vio das empresas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Acompanhar essas mudan\u00e7as e incorpor\u00e1-las ao planejamento regulat\u00f3rio \u00e9 parte essencial da estrat\u00e9gia de conformidade. Para isso, manter processos atualizados, documenta\u00e7\u00e3o consistente e decis\u00f5es bem fundamentadas ajudam a reduzir riscos, evitar atrasos e fortalecer a sustentabilidade regulat\u00f3ria dos produtos no mercado. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se voc\u00ea quiser receber atualiza\u00e7\u00f5es como essas regularmente, assine gratuitamente o <a href=\"https:\/\/sobelconsult.com\/pt-br\/?popup=810\">Sobel News Round Up<\/a> e mantenha-se informado sobre o que pode afetar sua empresa.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.<\/p>\n","protected":false},"author":12,"featured_media":27282,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_angie_page":false,"page_builder":"","footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[125],"tags":[561,533],"market":[501],"content_type":[517],"class_list":["post-27295","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cosmeticos-pt-br","tag-ingredientes-e-seguranca-do-produto-pt-br","tag-vigilancia-pos-mercado-pt-br","market-eua","content_type-noticias"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.8 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel<\/title>\n<meta name=\"description\" content=\"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais\" \/>\n<meta property=\"og:description\" content=\"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"Sobel\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-16T17:52:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-27T01:02:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Maik Endler\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maik Endler\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/\"},\"author\":{\"name\":\"Maik Endler\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#\\\/schema\\\/person\\\/7cb020654e2f235d6175a2734c2b5e28\"},\"headline\":\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais\",\"datePublished\":\"2026-01-16T17:52:31+00:00\",\"dateModified\":\"2026-10-27T01:02:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/\"},\"wordCount\":798,\"publisher\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cosmetic-products.jpg\",\"keywords\":[\"Ingredientes e seguran\u00e7a do produto\",\"Vigil\u00e2ncia p\u00f3s-mercado\"],\"articleSection\":[\"Cosm\u00e9ticos\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/\",\"url\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/\",\"name\":\"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cosmetic-products.jpg\",\"datePublished\":\"2026-01-16T17:52:31+00:00\",\"dateModified\":\"2026-10-27T01:02:11+00:00\",\"description\":\"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/recall-cosmeticos-fda\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cosmetic-products.jpg\",\"contentUrl\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cosmetic-products.jpg\",\"width\":1000,\"height\":667,\"caption\":\"cosmetic products over a table.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/\",\"name\":\"Sobel\",\"description\":\"Regulatory Consultancy\",\"publisher\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#organization\",\"name\":\"Sobel\",\"url\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Logo-Oficial-Website-White.webp\",\"contentUrl\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Logo-Oficial-Website-White.webp\",\"width\":741,\"height\":290,\"caption\":\"Sobel\"},\"image\":{\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/75043510\\\/admin\\\/dashboard\\\/\",\"https:\\\/\\\/www.instagram.com\\\/sobelconsult\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/pt-br\\\/#\\\/schema\\\/person\\\/7cb020654e2f235d6175a2734c2b5e28\",\"name\":\"Maik Endler\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/maik-endler-portrait-96x96.webp\",\"url\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/maik-endler-portrait-96x96.webp\",\"contentUrl\":\"https:\\\/\\\/sobelconsult.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/maik-endler-portrait-96x96.webp\",\"caption\":\"Maik Endler\"},\"description\":\"Mechanical engineer trained in Germany and former BSI auditor (Notified Body). Founder and CEO of Sobel, he leads regulatory strategy for medical devices, IVDs and cosmetics in Brazil, Europe, the UK, the US and Canada.\",\"sameAs\":[\"https:\\\/\\\/sobelconsult.com\\\/home\\\/about-us\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/maikendler\\\/\"],\"award\":[\"Top Medical Device Regulatory Consultant in Latin America 2025 (Healthcare Business Review)\"],\"knowsAbout\":[\"EU MDR\",\"EU IVDR\",\"ANVISA registration\",\"ISO 13485\",\"ISO 14971\",\"ISO 10993\",\"Notified Body audits\"],\"knowsLanguage\":[\"German\",\"English\",\"Portuguese\"],\"jobTitle\":\"Founder & CEO\",\"worksFor\":\"Sobel\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel","description":"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","og_locale":"pt_BR","og_type":"article","og_title":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais","og_description":"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.","og_url":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","og_site_name":"Sobel","article_published_time":"2026-01-16T17:52:31+00:00","article_modified_time":"2026-10-27T01:02:11+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","type":"image\/jpeg"}],"author":"Maik Endler","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Maik Endler","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#article","isPartOf":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/"},"author":{"name":"Maik Endler","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/7cb020654e2f235d6175a2734c2b5e28"},"headline":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais","datePublished":"2026-01-16T17:52:31+00:00","dateModified":"2026-10-27T01:02:11+00:00","mainEntityOfPage":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/"},"wordCount":798,"publisher":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","keywords":["Ingredientes e seguran\u00e7a do produto","Vigil\u00e2ncia p\u00f3s-mercado"],"articleSection":["Cosm\u00e9ticos"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","url":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/","name":"News: o novo cen\u00e1rio de recall de cosm\u00e9ticos no FDA e mais - Sobel","isPartOf":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","datePublished":"2026-01-16T17:52:31+00:00","dateModified":"2026-10-27T01:02:11+00:00","description":"Enquanto o FDA fortalece o recall de cosm\u00e9ticos, UE e China fazem atualiza\u00e7\u00f5es regulat\u00f3rias importantes.","inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/recall-cosmeticos-fda\/#primaryimage","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/01\/cosmetic-products.jpg","width":1000,"height":667,"caption":"cosmetic products over a table."},{"@type":"WebSite","@id":"https:\/\/sobelconsult.com\/pt-br\/#website","url":"https:\/\/sobelconsult.com\/pt-br\/","name":"Sobel","description":"Regulatory Consultancy","publisher":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sobelconsult.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/sobelconsult.com\/pt-br\/#organization","name":"Sobel","url":"https:\/\/sobelconsult.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.webp","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2024\/07\/Logo-Oficial-Website-White.webp","width":741,"height":290,"caption":"Sobel"},"image":{"@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/75043510\/admin\/dashboard\/","https:\/\/www.instagram.com\/sobelconsult\/"]},{"@type":"Person","@id":"https:\/\/sobelconsult.com\/pt-br\/#\/schema\/person\/7cb020654e2f235d6175a2734c2b5e28","name":"Maik Endler","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/10\/maik-endler-portrait-96x96.webp","url":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/10\/maik-endler-portrait-96x96.webp","contentUrl":"https:\/\/sobelconsult.com\/wp-content\/uploads\/2026\/10\/maik-endler-portrait-96x96.webp","caption":"Maik Endler"},"description":"Mechanical engineer trained in Germany and former BSI auditor (Notified Body). Founder and CEO of Sobel, he leads regulatory strategy for medical devices, IVDs and cosmetics in Brazil, Europe, the UK, the US and Canada.","sameAs":["https:\/\/sobelconsult.com\/home\/about-us\/","https:\/\/www.linkedin.com\/in\/maikendler\/"],"award":["Top Medical Device Regulatory Consultant in Latin America 2025 (Healthcare Business Review)"],"knowsAbout":["EU MDR","EU IVDR","ANVISA registration","ISO 13485","ISO 14971","ISO 10993","Notified Body audits"],"knowsLanguage":["German","English","Portuguese"],"jobTitle":"Founder & CEO","worksFor":"Sobel"}]}},"_links":{"self":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/27295","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/comments?post=27295"}],"version-history":[{"count":3,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/27295\/revisions"}],"predecessor-version":[{"id":46340,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/posts\/27295\/revisions\/46340"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/media\/27282"}],"wp:attachment":[{"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/media?parent=27295"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/categories?post=27295"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/tags?post=27295"},{"taxonomy":"market","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/market?post=27295"},{"taxonomy":"content_type","embeddable":true,"href":"https:\/\/sobelconsult.com\/pt-br\/wp-json\/wp\/v2\/content_type?post=27295"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}